Larvol Delta - Ocrelizumab-Discontinuation-After-Recurrent-Serious-Infections-in-Clinically-Stable-Primary-Progressive-Multiple-Sclerosis-A-Case-Report

Ocrevus (ocrelizumab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42770063

Lamisa Hassan; Rithvik Seri; Shane Wilson; Stephanie Hang; Tyler Lo

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next